Biome Australia Limited (BIO.AX)
AUD 0.47
(-5.05%)
AUD 0.47
(-5.05%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 1.88 Million AUD | -37.49% |
| 2023 | 3.02 Million AUD | 158.36% |
| 2022 | 1.16 Million AUD | 14.55% |
| 2021 | 1.02 Million AUD | 9.48% |
| 2020 | 932.47 Thousand AUD | 106.31% |
| 2019 | 451.97 Thousand AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.08 Million AUD | 77.95% |
| 2024 Q4 | 1.88 Million AUD | 0.0% |
| 2024 FY | 1.88 Million AUD | -37.49% |
| 2024 Q2 | 2.08 Million AUD | 0.0% |
| 2023 Q2 | 2.03 Million AUD | 0.0% |
| 2023 FY | 3.02 Million AUD | 158.36% |
| 2023 Q3 | 3.02 Million AUD | 48.76% |
| 2023 Q1 | 2.03 Million AUD | 56.22% |
| 2023 Q4 | 1.16 Million AUD | -61.29% |
| 2022 Q2 | 979.63 Thousand AUD | 0.0% |
| 2022 FY | 1.16 Million AUD | 14.55% |
| 2022 Q4 | 1.3 Million AUD | 0.0% |
| 2022 Q3 | 1.3 Million AUD | 32.71% |
| 2022 Q1 | 979.63 Thousand AUD | -4.04% |
| 2021 Q4 | 1.02 Million AUD | -0.0% |
| 2021 Q3 | 1.02 Million AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 FY | 1.02 Million AUD | 9.48% |
| 2020 FY | 932.47 Thousand AUD | 106.31% |
| 2019 FY | 451.97 Thousand AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | 212.447% |
| Acrux Limited | 147 Thousand AUD | -1184.746% |
| Actinogen Medical Limited | 108.82 Thousand AUD | -1635.362% |
| AnteoTech Limited | 221.85 Thousand AUD | -751.259% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 381.418% |
| Alterity Therapeutics Limited | 1.00 AUD | -188857600.0% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -1844.641% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Biotron Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | -56.162% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 8.93 Billion AUD | 99.979% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 82.228% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | -1645.386% |
| Dimerix Limited | - AUD | -Infinity% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | -34.783% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 315.286% |
| Immuron Limited | 1.58 Million AUD | -19.183% |
| Immutep Limited | 2.00 AUD | -94428750.0% |
| Imugene Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 2088.332% |
| Memphasys Limited | 164.76 Thousand AUD | -1046.252% |
| Nanollose Limited | - AUD | -Infinity% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 180.05% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | -60.506% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | -17.99 Million AUD | 110.494% |
| Race Oncology Limited | 16.4 Thousand AUD | -11415.011% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 291.265% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Starpharma Holdings Limited | 2.4 Million AUD | 21.571% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 89.09% |
| Tissue Repair Ltd | 214.72 Thousand AUD | -779.545% |
| Zelira Therapeutics Limited | 1.25 Million AUD | -50.807% |